Background. An accurate assessment of the predictors of long-term mortality in patients with infective endocarditis is not possible using retrospective data because of inherent treatment biases and predictable imbalances in the distribution of prognostic factors. Largely because of these limitations, the role of surgery in long-term survival has not been adequately studied.
In the presurgical era (i.e., before 1964), the overall cure rate of patients with infective endocarditis (IE) was reported to be ∼70% [1] . Remarkably, recent reports on the outcome of IE fail to show a significant improvement; the authors of most recent studies report 6-month mortality rates of 20%-35% [2, 3] . This lack of improvement in the mortality rate is perplexing given progressive improvements in surgical techniques, newer antimicrobial agents, and better diagnostic tools [4] , and it may reflect a disease that is fundamentally different than that described in historic reports.
It is widely accepted that mortality in patients with IE is related to the presence and severity of congestive heart failure, new valvular regurgitation, systemic embolization, and infection with staphylococci [2, 5, 6] and that the early use of surgery in certain patients with IE has been associated with better outcomes [7] [8] [9] [10] [11] . Although the consensus opinion is that the use of surgery for complicated native-valve IE is associated with reduced mortality [2, [5] [6] [7] [8] [9] , this has not been validated through randomized, controlled trials or prospective, long-term cohort studies. In addition, retrospective ob-servational case series are typically flawed by inherent treatment bias without adequate statistical adjustment. For example, the presence of stroke may prevent timely valve replacement and bias outcome assessment in patients who receive only medical therapy [12] .
Propensity score techniques are an important way to adjust for treatment bias in observational cohorts [13] [14] [15] [16] [17] . For instance, Vikram et al. [14] recently used retrospectively collected data and propensity score analysis to examine the impact of surgical therapy on mortality in patients with IE. In this study, surgery was independently associated with improved 6-month survival; however, this 6-month survival benefit was largely driven by a dramatic benefit in patients with acute, moderateto-severe heart failure.
Using data from a large, longitudinal, prospective cohort study, we designed this study to better understand the impact of surgery on the long-term survival of patients with IE.
MATERIALS AND METHODS
Study population and clinical data. Data for this study were obtained from the Duke University Prospective Cohort Study on Endocarditis. All study patients were hospitalized at Duke University Medical Center (Durham, NC) between 1 April 1996 and 31 December 2002. All patients met the modified Duke criteria for definite or possible endocarditis [18] . Data, obtained prospectively on each patient, included the following: demographic information; preexisting state of health; location of infection; information regarding previous episodes of IE; native or prosthetic valve status; echocardiographical, microbiological, and serological data; and, if surgery was performed, the type of surgery and any complications from this surgery. Most data were collected at the time of diagnosis (time 0); however, some data (e.g., regarding complications and hospital outcomes) were collected during the course of initial hospitalization.
Patients were included in the initial analysis if they had leftand/or right-side involvement of a native and/or prosthetic valve. For patients with 11 occurrence of IE, only the first episode was included in the analysis. Patients with cardiac device-related IE were also included. Our study was approved by the institutional review board at Duke University School of Medicine (Durham, NC).
Outcomes. The primary outcome was all-cause mortality at 5 years after discharge from initial hospitalization for the treatment of IE. Long-term survival was determined through examination of medical records at Duke University Medical Center and the National Death Index [19] . Median duration of follow-up for the patients in this study was 402 days (range, 0-2793 days).
Definitions. Use of systemic corticosteroid or other immunosuppressive therapy for 130 days was defined as immunosuppression. Presence of chronic, long-term vascular catheters was defined as the presence of permanent or semipermanent intravenous catheters (i.e., Hickman, port-acath, and permcath) at the time of onset of the episode of IE. Diabetes mellitus was adjudicated as present when it was documented in patient records as a comorbid condition. Systemic embolism was defined as clinical findings of embolism to any major arterial blood vessel; pulmonary embolism was excluded. Only surgery during the initial hospitalization for IE was evaluated. Short-term mortality was defined as death during initial hospitalization.
Statistical analysis. Differences between baseline characteristics of patients who did and did not undergo surgery were measured using the x 2 test for categorical variables and the Wilcoxon rank-sum test for continuous variables. Propensity score analysis was used to adjust for potential confounding. The development of the propensity model was done on the basis of the results of univariate analyses. Baseline variables found to have a univariate association with surgery ( ) P ! .1 were considered for the propensity score model in a stepwise fashion, with consideration for clinically plausible interactions. Propensity scores-the estimated probability that a patient will undergo surgery-were computed using maximum likelihood logistic regression analysis. The fit of the propensity model to the data was assessed using the concordance index [20] . Patients who underwent surgery were matched to patients who did not undergo surgery, using individual propensity scores. This matching scheme used the minimum absolute distance between patients' propensities for surgery [21] .
The matching tolerance was a propensity score difference of 0.075-that is, an individual medically managed patient was only matched to a surgically treated patient if the medically managed patient had a chance of undergoing surgery within 7.5% of the chance that a surgically treated patient had of undergoing surgery. For example, a patient with a 90% chance of undergoing surgery would not be matched with a patient with an 82% chance of undergoing surgery. Because an algorithm was sequentially employed for the matching of medically managed patients, each previous match was reexamined to determine whether an alternative medically managed patient would be a better match (i.e., would have a smaller difference in probabilities) before a new match was created. If the matching algorithm determined that a certain case patient was a better match than a previously matched case patient, this new case patient was substituted and the previously matched case patient was then considered to be available for future matching.
After propensity matching was performed, 2 cohorts of 51 patients each were identified. Unadjusted survival distributions for surgically and medically treated patients were compared using Kaplan-Meier curves and the log-rank test. To further adjust for potential confounding, a Cox proportional hazard regression analysis was used to assess long-term mortality, while controlling for comorbidities. The proportional hazards assumption was validated by inspection of the logarithmic survival curves and tests of proportionality for all time-dependent covariates. All analyses were performed using SAS software, versions 6.12 and 8.2 (SAS Institute).
RESULTS

Patient characteristics.
Of the 426 patients who initially entered in the study, 333 patients (78%) had left-side-associated infections without concomitant intracardiac devices (table 1) . Of these 333 patients, 78 (23%) underwent valvular surgery.
In the group of patients with left-side-associated IE, patients who underwent combined medical-surgical therapy were more likely to be male and to have new aortic valvular regurgitation and vegetation, intracardiac abscesses, and class IV congestive heart failure symptoms (table 1) . Patients receiving combined medical-surgical therapy were also less likely to have renal disease requiring hemodialysis, diabetes, cancer, or a history of chronic immunosuppressive therapy. The most common causative microorganism for patients with IE in both treatment groups was Staphylococcus aureus, but there was a higher frequency of S. aureus infection in patients receiving medical therapy (40%) than in those receiving combined medical-surgical therapy (27%;
). Of the 333 patients with left-side-P p .036 associated infections, 23 patients had coagulase-negative staphylococcal infection and 10 of 23 (43.5%) were patients with prosthetic-valve IE.
Analysis of patient characteristics and mortality during the 5-year follow-up period. In patients with left-side-associated IE, the 5-year mortality rate was 48.6% (162 of 333 patients died). Patients who died were more likely to have the following characteristics: older age, renal disease requiring hemodialysis, diabetes mellitus, HIV infection, or cancer (table 2) . Patients who died were also more likely to have physical findings of IE at the time of initial examination, to have persistently positive blood sample cultures, and to have S. aureus as the infecting pathogen. The sex distribution of patients who were alive at 5 years after initial hospitalization was similar to that of survivors. Patients who were alive at 5 years were significantly more likely to have undergone surgery for their episode of IE ( ). P ! .001 Survival analysis techniques were employed to understand long-term survival in more detail. Separation of the survival curve of patients with medically treated IE from the survival curve of patients with surgically treated IE occurred early, with the greatest separation occurring within the first 180 days of follow-up (figure 1). Notably, after 500 days of follow-up, mortality rates among the 2 groups were similar throughout the rest of the long-term follow-up period.
Propensity scoring and predictors of surgery in patients with left-side-associated IE. A propensity model was developed for the likelihood of surgery. This model was based on the results of the univariate analysis that examined associations between the use of surgery and patient characteristics. The patient characteristics that were considered for the multivariate model included age, transfer from an outside hospital, the presence of congestive heart failure, and an intracardiac abscess. In addition, important interactions between characteristics and the likelihood of surgery were also examined. On the basis of this analysis, interactions between evidence of IE on physical examination and staphylococcal IE, as well as the presence of chronic vascular catheters and history of hemodialysis, were associated with the use of surgery. Notably, evidence of IE on physical examination was not associated with surgical intervention. In addition, Staphylococcus species infection was not predictive of surgery, regardless of whether there was evidence of IE on physical examination (table 3) . The final propensity score model yielded excellent discriminative characteristics (concordance index ). p 0.87 Matching and characteristics of matched cohorts. Following assignment of propensity scores, patients were matched on the basis of the minimum absolute difference between their propensities for surgery. This matching process yielded 2 cohorts of 51 patients (table 4). Patients in these 2 matched cohorts were similar in all variables except 1: patients undergoing surgery were less likely to have an abscess documented by echocardiography ( ). However, when the P p .035 presence of abscess as determined by echocardiography or surgery was used, the incidence of abscess was similar in the medical and medical-surgical therapy groups (23.5% vs. 21.6%;
). P p . 813 Patients who could not be successfully matched using the above process ( ) were analyzed separately with respect n p 231 to the occurrence of surgery. Patients undergoing surgery who could not be matched were more likely to have the following characteristics: prosthetic valve endocarditis, younger age, male sex, presence of a new murmur, pulmonary edema at initial presentation to a health care facility, aortic regurgitation, congestive heart failure (particularly class IV congestive heart failure), cardiac conduction abnormalities, vegetations, or an abscess detected by echocardiography. These patients were also less likely to have diabetes, renal disease requiring hemodialysis, long-term vascular catheters, or evidence of IE on physical examination.
Predictors of survival within the matched cohort. 
4.44) (table 5)
. Notably, the survival curves for the 2 propensitymatched cohorts were parallel through the first 40 days of follow-up (figure 2), likely representing the balance between perioperative risk and the acute IE disease process. Following 40 days, the survival curves separated, revealing a distinct survival advantage through 1 year of follow-up.
DISCUSSION
Surgery has become a mainstay in the therapy of complicated IE [22] [23] [24] [25] . However, the use and timing of surgery in an individual patient with IE is often a difficult and complex clinical decision. Unfortunately, in the current era of evidencebased medicine, there is very little high-quality evidence to assist the practitioner in identifying patients who are at high risk of serious complications, including death. The present study was designed to use the improved precision of a large, longitudinal, prospective cohort study to thoroughly understand the impact of surgery on the long-term survival of patients with IE. From this study, we have been able to make several important observations. First, there are important clinical characteristic differences between medical only and medical-surgical treatment groups. Although this finding may be intuitive, few studies have sought to quantitate differences in clinical characteristics between patients with IE who are treated surgically and patients treated with medical therapy alone. Previous investigators have shown that comorbid diseases are strong predictors of mortality in patients with infective endocarditis [14] . In addition, there is evidence that outcomes are similar for patients receiving surgical or medical therapy when clinical characteristics that may preclude surgery are excluded from comparison [11] . Taken together, our findings support the findings of both of these previous studies, and provide further evidence that clinical differences are important when examining the effect of treatment decisions on outcome. Unadjusted Kaplan-Meier survival curves of patients with infective endocarditis (IE) who received only medical therapy versus patients with IE who received surgical and medical therapy. At 6 months after treatment, 252 patients were considered to be at risk; at 1 year, 213 patients were at risk; at 2 years, 142 patients were at risk; at 3 years, 97 patients were at risk; at 4 years, 70 patients were at risk; and at 5 years, 40 patients were at risk. Second, survival curves separate early. In this large, longitudinal, prospective cohort study, we found that the survival curves of patients with left-side-associated IE who were treated medically versus those who were treated surgically separated early and continued to be separate through the first 18 months of follow-up. After 18 months, the rate of mortality in each group was nearly parallel. Despite a high rate of mortality among patients receiving surgical therapy, the survival curves ( figure 1) show a dramatically worse rate of survival in the medical therapy group. One possible explanation for this finding is that a high percentage of patients with surgical indications were not treated surgically because of important contraindications to surgery. Additionally, it is possible that current methods do not allow clinicians to identify all high-risk patients who are receiving medical therapy early enough in their episode of IE to allow them to also receive surgical therapy.
Third, clinically important predictors of outcome can be identified. To control for confounding treatment biases and differences in the distribution of prognostic factors between the 2 treatment groups, we assigned propensity scores to patients with left-side-associated IE who did not have concurrent, nonvalvular cardiac devices. This method allowed us to match 51 Figure 2 . Adjusted Kaplan-Meier survival curves of propensity-matched patients with infective endocarditis (IE) who received only medical therapy versus patients with IE who received surgical and medical therapy. At 30 days after treatment, 76 patients were considered to be at risk; at 90 days, 68 patients were at risk; at 180 days, 61 patients were at risk; at 270 days, 58 patients were at risk; and at 365 days, 56 patients were at risk.
patients who received combined medical-surgical therapy with 51 patients who received medical therapy only. Notably, these matched groups were similar in nearly all observed covariates. The use of early surgery was the only factor associated with improved long-term survival. Survival analysis provided evidence that this benefit occurred early in the follow-up period, with survival curves that separated at ∼40 days. Therefore, patients who received early surgical therapy had improved survival that occurred early and was durable through 600 days (data not shown). After that time point, the survival curves for the surgical and nonsurgical groups were more similar.
Multivariable Cox proportional hazards regression analysis of the propensity matched cohort revealed several key observations-specifically, that the use of surgery was independently associated with reduced mortality (HR, 0.27; 95% CI, 0.13-0.55). This finding confirms recent studies that have demonstrated improved 6-month survival of patients with left-sideassociated IE who were treated with surgical therapy [14] .
Additionally, because our study included a median duration of follow-up of 402 days, our data confirm that surgical therapy confers a long-term survival benefit in patients with similar indications for surgery. We were also able to identify several other independent predictors of long-term mortality, including diabetes mellitus, chronic indwelling central catheters, and paravalvular complications.
These findings extend those of Vikram et al. [14] , who recently reported a 6-month survival advantage in patients with IE who were treated with early surgical therapy. In this study, after adjustment for heterogeneity and confounding, surgical therapy was associated with a survival benefit at 6 months after treatment (HR, 0.40; 95% CI, 0.18-0.91;
). In the pro-P p .03 pensity-matched group, patients with moderate-to-severe congestive heart failure experienced the greatest reduction in 6-month mortality with valve surgery (14% vs 51%; HR, 0.22; 95% CI, 0.09-0.53;
). We have found that this early P p .001 survival advantage observed in matched cohorts can be extended into the long-term follow-up period. In addition, we have found that several clinical characteristics that can be identified at initial hospitalization are independently associated with long-term mortality, even after controlling for the use of surgery in a propensity-matched cohort. These important long-term predictors include diabetes mellitus, paravalvular complications, and the presence of a chronic vascular catheter.
Limitations. This study had several limitations. Our study was observational; although propensity scoring analyses reduce the effect of treatment bias when randomized, controlled studies are not feasible, this statistical method cannot completely control for potential confounding [13] . Our model was based on patient characteristics and findings that were documented in our patients' medical records, and cannot account for variables that were not collected. Because data for this study were collected at a single tertiary care center, the presence of confounding by referral bias is acknowledged, although we attempted to reduce this confounding by including "transfer from an outside hospital" as a variable in our propensity score model. The inclusion of patients with prosthetic valve endocarditis into the group of patients with native-valve infections may be considered by some to be a weakness, because the surgical management of the former condition is affected by a variety of technical factors. However, as discussed previously, the matched groups were similar in nearly all observed covariates, and we believe this matching schema largely overcomes the limitations of including patients with prosthetic and native-valve endocarditis.
In conclusion, to our knowledge, the present study is the first large, longitudinal, prospective cohort study to thoroughly examine the impact of surgery on the long-term survival of patients with IE. By using statistical techniques to minimize the impact of known treatment bias, we were able to determine that surgical therapy in patients with left-side-associated IE is a strong independent predictor of long-term survival. In addition, other independent predictors of long-term mortality, such as diabetes mellitus and paravalvular complications, identify high-risk patient groups for long-term mortality. The use of surgery was independently predicted by age, the presence of heart failure, and intracardiac abscess. Patients with these characteristics represent those who may reap the most benefit from the use of early surgery and who should be considered for early, aggressive therapy, including the use of intracardiac surgery. Further studies are needed to understand the impact of surgical treatment in broader patient groups.
